Tandem Mass Spectrometry - The Future of Newborn Screening of Inborn Errors of Metabolism
Authors:
P. Chrastina; S. Šťastná; H. Myšková; J. Zeman
Authors‘ workplace:
Ústav dědičných metabolických poruch VFN a 1. LF UK, Prahapřednosta prof. MUDr. M. Elleder, DrSc.
Published in:
Čes-slov Pediat 2003; (7): 464-467.
Category:
Overview
Tandem mass spectrometry is a new technology used in newborn screening of inborn errors of metabolism.This technology significantly increases preventive effect of newborn screening. It enables to screen simultaneouslywithin the same analytical run not only phenylketonuria but also 24 others inborn errors of metabolism froma dried blood spot. The early diagnosis and treatment are now possible by to date late or no diagnosing disorders.The overall incidence of detectable inborn errors of metabolism bymeasurement of amino acids and acylcarnitinesis 1:4500.
Key words:
inborn errors of metabolism, newborn screening, tandem mass spectrometry
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2003 Issue 7
Most read in this issue
- MCAD Deficiency - Our Experience with Four Symptomatic Patients
- Megaloblastic Anemia 1 (Imerslund-Gräsbeck)
- Tandem Mass Spectrometry - The Future of Newborn Screening of Inborn Errors of Metabolism
- Clinical and Molecular Analyses in Eight Children with Congenital Disorders of Glycosylation